신생아 경련성 질환의 항경련제 요법

Anticonvulsant Therapy in Neonate

  • 유재은 (아주대학교 의과대학 소아과학교실)
  • Yu, Jae-Eun (Department of Pediatrics, Ajou University School of Medicine)
  • 발행 : 2009.05.31

초록

The immature neonatal brain is susceptible to the development of seizures. Seizures occur in 1% to 5% of infants during the neonatal period. Neonatal seizures are most commonly associated with serious acute illnesses, such as hypoxic-ischemic encephalopathy, birth trauma, metabolic disturbances, or infections. Thus, newborn infants with seizures are at risk for neonatal death and survivors are at risk for neurologic impairment, developmental delay, and subsequent epilepsy. Experimental data have also raised concerns about the potential adverse effects of the currently used anticonvulsants in neonates on brain development. Therefore, in the management of neonatal seizures, confirmatory diagnosis and optimal, but shorter, duration of anticonvulsant therapy is essential. Nevertheless, there has been substantial progress in understanding the developmental mechanisms that influence seizure generation and responsiveness to anticonvulsants. The currently used therapies have limited efficacy and the treatment of neonatal seizures has not significantly changed in the past several decades, This review includes an overview of current approaches to the treatment of neonatal seizures.

키워드

참고문헌

  1. Ronen GM , Penney S, Andrews W. The epidemiology of clinicaI neonatal seizures in Newfoundland: a population-based study. J Pediatr 1999:134 :71-5. https://doi.org/10.1016/S0022-3476(99)70374-4
  2. Bassan H, Bental Y. Shany F, Berger I. Froom P, Levi L, et at. Neonatal seizures: dilemmas in workup and management. Pediatr Neurol 2008;38: 415-21. https://doi.org/10.1016/j.pediatrneurol.2008.03.003
  3. Bartha AI. Shen .J, Katz KH, Mischel RE. Yap KR. Ivacko JA, et al. Neonatal seizures: multicenter variability in current treatment practices. Pediatr Neurol 2007:37:85-90. https://doi.org/10.1016/j.pediatrneurol.2007.04.003
  4. Guillet R. Kwon JM. Prophylactic phenobarbital adminisiration after resolution of neonatal seizures: survey of current practice. Pediatrics 2008;122:731-5. https://doi.org/10.1542/peds.2007-3278
  5. Carmo KB. Barr P. Drug treatment of neonatal seizures by neonatologists and paediatric neurologists. J Paediatr Child Health 2005 ; 41: 313-6. https://doi.org/10.1111/j.1440-1754.2005.00638.x
  6. Wheless JW, Clarke DF. Arzimanoglou A. Carpenter D. Treatment of Pediatric epilepsy: European expert opinion, 2007. Epileptic Disord 2007;9:353-42.
  7. Volpe.J.J. Neurology of the newborn. 6th ed. Philadelphia: WB Saunders Co, 2008:203-44.
  8. Ben- Ari Y. Basic developmental rules and their implications for epilepsy in the immature brain. Epileptic Disord 2006: 8: 91-102.
  9. Veliskova J, Claudio OI, Galanopoulou AS. Lado FA, Ravizza T, Velisek L. et al. Seizures in the developing brain. Epilepsia 2004;45 suppl 8:6-12. https://doi.org/10.1111/j.0013-9580.2004.458002.x
  10. Haut SR. Veliskova J, Moshe SL. Susceptibility of immature and adult brains to seizure effects, Lancet Neurol 2004;3;608-17. https://doi.org/10.1016/S1474-4422(04)00881-6
  11. Holopainen IE. Seizures in the developing brain: cellular and molecular mechanisms of neuronal damage, neurogenesis and cellular recrganization. Neurochem Int 2008;52:935- 47. https://doi.org/10.1016/j.neuint.2007.10.021
  12. Clancy RR. Legido A. Lewis D. Occult neonatal seizures. Epilepsia 1988:29: 256-61. https://doi.org/10.1111/j.1528-1157.1988.tb03715.x
  13. Murray DM, Boylan GB, Ali I. Ryan CA, Murphy BP. Connolly S , Defining the grap between electrographic seizure burden, clinical expression and staff recognition of neonatal seizures. Arch Dis Child Fetal Neonatal Ed 2008; 93: F187-91. https://doi.org/10.1136/adc.2005.086314
  14. Alfonso I, Papazian O, Litt R, Villalobos R, Acosta JI. Similar brain SPECT finding in subclinical and clinical seizures in two neonates with hemime-galencephaly. Pediatr Neurol 1998; 19: 132-4. https://doi.org/10.1016/S0887-8994(98)00030-7
  15. Boylan GB. Rennie JM, Pressler RM, Wilson G. Morton M, Binnie CD, Phenobarbitone, neonatal seizures, and video-EEG. Arch Dis Child Fetal Neonatal Ed 2002;86:F165-70. https://doi.org/10.1136/fn.86.3.F165
  16. Bittigau P, Sifringer M, Genz K, Reith E, Pospischil D. Govindarajalu S, et al. Antiepileptic drug and apoptotic neurodegeneration in the developing brain. Proc Natl Acad Sci USA 2002;99:15089-94. https://doi.org/10.1073/pnas.222550499
  17. Calandre EP, Dominguez-Granados R, Gomez-Rubio M, Molina-Font JA. Cognitive effects of long- term treatment with phenobarbital and valproic acid in school children. Acta Neurol Scand 1990:81;504-6 https://doi.org/10.1111/j.1600-0404.1990.tb01008.x
  18. Farwell JR. Lee YJ. Hirtz DG. Sulzbacher SI, Ellenberg JH, Nelson KB. Phenobarbital for febrile seizures--effects on intelligence and on seizure recurrence. N Engl J Med 1990:322:364-9. https://doi.org/10.1056/NEJM199002083220604
  19. Riva D. Devoti M. Discontinuation of phenobarbital in children: effects on neurocognitive behavior. Pediatr Neurol 1896;14:36-40. https://doi.org/10.1016/0887-8994(95)00224-3
  20. Sulzbacher S. Farwell JR, Temkin N, Lu AS, Hirtz DG. Late cognitive effects of early treatment with phenobarbiltal. Clin Pediatr (Phila) 1999;38:387-94. https://doi.org/10.1177/000992289903800702
  21. Ben- Ari Y, Gaiarsa JL. Tyzio R, Khazipov R. GABA: a pioncer transmitter that excites immature neurons and generates primitive oscillations. Physiol Rev 2007;87:1215-84. https://doi.org/10.1152/physrev.00017.2006
  22. Clancy RR; Neurology Group on Neonatal Seizures. The newborn drug development initiative workshop: Summary proceedings from the neurology group on neonatal seizures. Clin Ther 2006; 28 : 1342-52 https://doi.org/10.1016/j.clinthera.2006.09.004
  23. Boylan GH, Rennie JM. Chorley G, Pressler RM. Fox GF, Farrer K, et al. Second-line anticonvulsant treatment of neonatal seizures: a video- EEG monitoring study. Neurology 2004;62:486-8. https://doi.org/10.1212/01.WNL.0000106944.59990.E6
  24. Silverstein FS, Jensen FE. Neonatal seizures. Ann Neurol 2007;62:112-20 https://doi.org/10.1002/ana.21167
  25. Meador KJ, Baker GA, Finnell RH, Kalayjian LA, Liporace JD, Loring DW, et al. In utero antiepileptic drug exposure: fetal death and malformations. Neurology 2006;67:407-12. https://doi.org/10.1212/01.wnl.0000227919.81208.b2
  26. Gamstorp I, Sedin G. Neonatal convulsions treated with continuous, intravenous infusion of diazepam. Ups J Med Sic 1982;87:143-9. https://doi.org/10.3109/03009738209178419
  27. Hu KC, Chiu NC, Ho CS, Lee ST, Shen EY. Continuous midazolam infusion in the treatment of uncontrollable neonatal seizures. Acta Paediatr Taiwan 2003;44:279-81.
  28. Bonati M, Marraro G, Celardo A, Passerini F, Schieroni F, Spada P, et al. Thiopental efficacy in phenobarbital-resistant neonatal seizures. Dev Pharmacol Ther 1990;15:16-20. https://doi.org/10.1159/000457614
  29. Alfonso I, Alvarez LA, Gilman J, Dunoyer C, Yelin K, Papazian O. Intravenous valproate dosing in neonates. J Child Neurol 2000;15:827-9. https://doi.org/10.1177/088307380001501216
  30. Gal P, Oles KS, Gilman JT, Weaver R. Valproic acid efficacy, toxicity, and pharmacokinetics in neonates with intractable seizures. Neurology 1988; 38:467-71. https://doi.org/10.1212/WNL.38.3.467